G protein subunit alpha i3
Ultimo aggiornamento 18 Ago 2025
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
The GNAI3 gene provides instructions for making one part, the GNAI3 inhibitory alpha subunit, of a protein complex called a guanine nucleotide-binding protein (G protein). G proteins are composed of three protein subunits: alpha, beta, and gamma. Each of these subunits is produced from a different gene.
Scelte video per GenesVideo library
Normal function
The GNAI3 gene provides instructions for making one part, the GNAI3 inhibitory alpha subunit, of a protein complex called a guanine nucleotide-binding protein (G protein). G proteins are composed of three protein subunits: alpha, beta, and gamma. Each of these subunits is produced from a different gene.
Through a process called signal transduction, G proteins trigger a complex network of signaling pathways within cells. These pathways help transmit information from the outside of the cell to the inside of the cell. Specifically, G proteins that are made with the GNAI3 inhibitory alpha subunit reduce (inhibit) the activity of an enzyme called adenylyl cyclase. This enzyme is important for transmitting information within cells. By influencing many cell activities, G protein signaling helps cells grow and divide or take on specialized functions.
Studies suggest that G protein signaling that involves the GNAI3 inhibitory alpha subunit contributes to the development of the first and second pharyngeal arches. During early development, these structures develop into the bones and tissues of the head and face, including the jawbones, facial muscles, and inner and outer ears.
Conditions referring to this gene or chromosome
Altri nomi
87U6
ARCND1
ARCODS
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3
guanine nucleotide binding protein, alpha-inhibiting activity polypeptide 3
guanine nucleotide-binding protein G(k) subunit alpha
HG1A
Related patient information and medicines

Patient information leaflet
Cancro primario al fegato
Weight loss Unintentional. Many people who develop primary liver cancro will already have symptoms associated with scarring of the liver (cirrhosis). If you already have cirrhosis and your health becomes worse quite quickly, the cause may be a liver cancer which has developed. Everyone with cirrhosis should be having regular monitoring with an.

Patient information leaflet
Test di funzionalità epatica
What are the main Funzione epatica tests. The usual liver function tests typically include the following: Bilirubin. Albumin. Total protein. Transferases (AST or SGOT and ALT or SGPT). Gamma GT. Creatine kinase. Immunoglobulins (antibodies made in response to various challenges including allergies Allergies , infections, some blood disorders and.

Patient information leaflet
Dieta Dukan
The final two phases involve re-introduction di ricchi with an aim to help dieters. There is no calorie restriction and you are permitted to eat as much of the allowed foods as you like. For every stage of the Dukan diet, you are required to eat a limited portion of oat bran daily. The four phases of the Dukan diet 1. Attack phase The attack phase.

Patient information leaflet
Sindrome nefrosica
Nephrotic syndrome is a condition where the 'filters' in the kidney become 'leaky' and large amounts of proteine leak from the blood into the urine. The main symptom is fluid retention (oedema) which is mainly due to the low protein level in the blood. Various diseases can cause nephrotic syndrome, some more serious than others. Treatment and.

Patient information leaflet
Screening per la sindrome di Down
This is so that you can have the combined test which is the recommended screening strategy in the first trimester of pre... What Down's syndrome screening tests are available? 10-14 weeks - combined test The standard test for Down's syndrome includes a combination of a nuchal translucency scan ( also called the NT scan - more details below) and a.

Patient information leaflet
Posso prendere Rivaroxaban e Tamsulosina insieme?
However, both medicines can occasionally cause dizziness or lightheadedness,... Taking them together might slightly increase the chance of feeling faint. Why this happens Rivaroxaban is an anticoagulant (blood thinner) and tamsulosin is an alpha-blocker used for prostate symptoms. They are processed by different pathways in the liver and do not.
Ulteriori letture e riferimenti
- G protein subunit alpha i3; MedlinePlus, National Library of Medicine.
- Baron B, Fernandez MA, Toledo F, Le Roscouet D, Mayau V, Martin N, Buttin G, Debatisse M. The highly conserved Chinese hamster GNAI3 gene maps less than 60 kb from the AMPD2 gene and lacks the intronic U6 snRNA present in its human counterpart. Genomics. 1994 Nov 15;24(2):288-94. doi: 10.1006/geno.1994.1618.
- Blatt C, Eversole-Cire P, Cohn VH, Zollman S, Fournier RE, Mohandas LT, Nesbitt M, Lugo T, Jones DT, Reed RR, et al. Chromosomal localization of genes encoding guanine nucleotide-binding protein subunits in mouse and human. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7642-6. doi: 10.1073/pnas.85.20.7642.
- Gordon CT, Vuillot A, Marlin S, Gerkes E, Henderson A, AlKindy A, Holder-Espinasse M, Park SS, Omarjee A, Sanchis-Borja M, Bdira EB, Oufadem M, Sikkema-Raddatz B, Stewart A, Palmer R, McGowan R, Petit F, Delobel B, Speicher MR, Aurora P, Kilner D, Pellerin P, Simon M, Bonnefont JP, Tobias ES, Garcia-Minaur S, Bitner-Glindzicz M, Lindholm P, Meijer BA, Abadie V, Denoyelle F, Vazquez MP, Rotky-Fast C, Couloigner V, Pierrot S, Manach Y, Breton S, Hendriks YM, Munnich A, Jakobsen L, Kroisel P, Lin A, Kaban LB, Basel-Vanagaite L, Wilson L, Cunningham ML, Lyonnet S, Amiel J. Heterogeneity of mutational mechanisms and modes of inheritance in auriculocondylar syndrome. J Med Genet. 2013 Mar;50(3):174-86. doi: 10.1136/jmedgenet-2012-101331. Epub 2013 Jan 12.
- Li Q, Jiang Z, Zhang L, Cai S, Cai Z. Auriculocondylar syndrome: Pathogenesis, clinical manifestations and surgical therapies. J Formos Med Assoc. 2023 Sep;122(9):822-842. doi: 10.1016/j.jfma.2023.04.024. Epub 2023 May 17.
- Rieder MJ, Green GE, Park SS, Stamper BD, Gordon CT, Johnson JM, Cunniff CM, Smith JD, Emery SB, Lyonnet S, Amiel J, Holder M, Heggie AA, Bamshad MJ, Nickerson DA, Cox TC, Hing AV, Horst JA, Cunningham ML. A human homeotic transformation resulting from mutations in PLCB4 and GNAI3 causes auriculocondylar syndrome. Am J Hum Genet. 2012 May 4;90(5):907-14. doi: 10.1016/j.ajhg.2012.04.002.
- Romanelli Tavares VL, Zechi-Ceide RM, Bertola DR, Gordon CT, Ferreira SG, Hsia GS, Yamamoto GL, Ezquina SA, Kokitsu-Nakata NM, Vendramini-Pittoli S, Freitas RS, Souza J, Raposo-Amaral CA, Zatz M, Amiel J, Guion-Almeida ML, Passos-Bueno MR. Targeted molecular investigation in patients within the clinical spectrum of Auriculocondylar syndrome. Am J Med Genet A. 2017 Apr;173(4):938-945. doi: 10.1002/ajmg.a.38101.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

